AAAAAA

   
Results: 1-9 |
Results: 9
APPLICATION OF A FAS LIGAND ENCODING A RECOMBINANT ADENOVIRUS VECTOR FOR PROLONGATION OF TRANSGENE EXPRESSION
Authors: ZHANG HG BILBAO G ZHOU T CONTRERAS JL GOMEZNAVARRO J FENG MZ SAITO I MOUNTZ JD CURIEL DT
Citation: Hg. Zhang et al., APPLICATION OF A FAS LIGAND ENCODING A RECOMBINANT ADENOVIRUS VECTOR FOR PROLONGATION OF TRANSGENE EXPRESSION, Journal of virology, 72(3), 1998, pp. 2483-2490
MODULATION OF BCL-2 PROTEIN-LEVELS BY AN INTRACELLULAR ANTI-BCL-2 SINGLE-CHAIN ANTIBODY INCREASES DRUG-INDUCED CYTOTOXICITY IN THE BREAST-CANCER CELL-LINE MCF-7
Authors: PICHE A GRIM J RANCOURT C GOMEZNAVARRO J REED JC CURIEL DT
Citation: A. Piche et al., MODULATION OF BCL-2 PROTEIN-LEVELS BY AN INTRACELLULAR ANTI-BCL-2 SINGLE-CHAIN ANTIBODY INCREASES DRUG-INDUCED CYTOTOXICITY IN THE BREAST-CANCER CELL-LINE MCF-7, Cancer research, 58(10), 1998, pp. 2134-2140
ADVANCES IN ADENOVIRAL VECTORS FOR CANCER GENE-THERAPY
Authors: BILBAO G GOMEZNAVARRO J CONTRERAS JL CURIEL DT
Citation: G. Bilbao et al., ADVANCES IN ADENOVIRAL VECTORS FOR CANCER GENE-THERAPY, Expert opinion on therapeutic patents, 7(12), 1997, pp. 1427-1446
ACTIVITY OF SINGLE-CHAIN ANTIBODIES THAT SELECTIVELY BLOCK THE EXPRESSION OF BCL-2 AND BAG-1 ANTI-APOPTOTIC PROTEINS
Authors: PICHE A GOMEZNAVARRO J GRIM JE REED JC CURIEL DT
Citation: A. Piche et al., ACTIVITY OF SINGLE-CHAIN ANTIBODIES THAT SELECTIVELY BLOCK THE EXPRESSION OF BCL-2 AND BAG-1 ANTI-APOPTOTIC PROTEINS, Journal of acquired immune deficiency syndromes and human retrovirology, 14(4), 1997, pp. 117-117
CHEMOSENSITIZATION OF OVARIAN-CANCER CELLS MEDIATED BY INTRACELLULAR EXPRESSION OF AN ANTI-BCL-2 SINGLE-CHAIN ANTIBODY
Authors: PICHE A GRIM J RANCOURT C GOMEZNAVARRO J ALVAREZ R SIEGAL GP CURIEL DT
Citation: A. Piche et al., CHEMOSENSITIZATION OF OVARIAN-CANCER CELLS MEDIATED BY INTRACELLULAR EXPRESSION OF AN ANTI-BCL-2 SINGLE-CHAIN ANTIBODY, Cancer gene therapy, 4(6), 1997, pp. 11-11
RECOMBINANT ADENOVIRAL VECTORS CAN BE TARGETED THROUGH THE FIBROBLASTGROWTH-FACTOR RECEPTOR PATHWAY INTO OVARIAN TUMOR-CELL LINES AND PRIMARY-CANCER CELLS
Authors: GOMEZNAVARRO J ROGERS BE CURIEL DT
Citation: J. Gomeznavarro et al., RECOMBINANT ADENOVIRAL VECTORS CAN BE TARGETED THROUGH THE FIBROBLASTGROWTH-FACTOR RECEPTOR PATHWAY INTO OVARIAN TUMOR-CELL LINES AND PRIMARY-CANCER CELLS, Cancer gene therapy, 4(6), 1997, pp. 66-66
PRIMARY OVARIAN-CANCER CELLS SUSTAIN THE TRANSCOMPLEMENTATION OF A REPLICATION-INCOMPETENT ADENOVIRUS AND PRODUCE PROGENY VIRUS
Authors: GOMEZNAVARRO J RANCOURT C ALVAREZ R SIEGAL G GARVER RI CURIEL DT
Citation: J. Gomeznavarro et al., PRIMARY OVARIAN-CANCER CELLS SUSTAIN THE TRANSCOMPLEMENTATION OF A REPLICATION-INCOMPETENT ADENOVIRUS AND PRODUCE PROGENY VIRUS, Cancer gene therapy, 4(6), 1997, pp. 72-72
CISPLATIN AND UFT MODULATED WITH LEUCOVORIN FOR THE TREATMENT OF ADVANCED NON-SMALL-CELL LUNG-CANCER
Authors: FELIU J GONZALEZBARON M ESPINOSA E DECASTRO J ORDONEZ A ZAMORA P GOMEZNAVARRO J ESPINOSA J VILCHES Y DELAGANDARA I
Citation: J. Feliu et al., CISPLATIN AND UFT MODULATED WITH LEUCOVORIN FOR THE TREATMENT OF ADVANCED NON-SMALL-CELL LUNG-CANCER, American journal of clinical oncology, 19(2), 1996, pp. 121-124
TREATMENT OF PATIENTS WITH ADVANCED GASTRIC-CARCINOMA WITH THE COMBINATION OF ETOPOSIDE PLUS ORAL TEGAFUR MODULATED BY URACIL AND LEUCOVORIN - A PHASE-II STUDY OF THE ONCOPAZ COOPERATIVE GROUP
Authors: FELIU J BARON MG GARCIAGIRON C ESPINOSA E GARCIAALFONSO P BELON J BLANCO E GARRIDO P ORDONEZ A GOMEZNAVARRO J ZAMORA P
Citation: J. Feliu et al., TREATMENT OF PATIENTS WITH ADVANCED GASTRIC-CARCINOMA WITH THE COMBINATION OF ETOPOSIDE PLUS ORAL TEGAFUR MODULATED BY URACIL AND LEUCOVORIN - A PHASE-II STUDY OF THE ONCOPAZ COOPERATIVE GROUP, Cancer, 78(2), 1996, pp. 211-216
Risultati: 1-9 |